StockWatch
·
Other Pharmaceuticals
Quarterly UpdatesJul 7, 2026, 09:30 AM

Cosmos Health Q2 Revenue $19.4M (+31.5%); Repurchases $700K Shares

AI Summary

Cosmos Health Inc. announced preliminary record revenue for the second quarter and first half of 2026. Q2 2026 revenue is expected to be approximately $19.4 million, a 31.5% increase from Q2 2025, and first-half revenue is projected at $37.3 million, up 31% from H1 2025. Additionally, the company reported repurchasing 3,640,000 shares for about $700,000 under its $5 million buyback program, with open market purchases continuing.

Key Highlights

  • Preliminary Q2 2026 revenue reached approximately $19.4 million, a 31.5% increase year-over-year.
  • Preliminary first-half 2026 revenue was approximately $37.3 million, up 31% from H1 2025.
  • Both Q2 and H1 2026 revenue figures represent record highs for the company.
  • Cosmos Health repurchased 3,640,000 shares for approximately $700,000 as of July 6, 2026.
  • The share repurchase is part of an ongoing $5 million buyback program.